Rigel Pharmaceuticals reported $49.2M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US USD 88.08M 23.66M
Amgen AMGN:US USD 4.61B 695M
Anika Therapeutics ANIK:US USD 46.29M 227K
Arrowhead Research ARWR:US USD 104.68M 10.72M
AstraZeneca AZN:LN USD 10.11B 376M
Astrazeneca AZN:US USD 10.11B 376M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Celldex Therapeutics CLDX:US USD 29.5M 1.4M
Daiichi Sankyo 4568:JP JPY 308.93B 42.65B
Eli Lilly And LLY:US USD 5.47B 200.3M
Halozyme Therapeutics HALO:US USD 106.99M 21.41M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Immunogen IMGN:US USD 100.73M 7.92M
Intrexon XON:US USD 23.56M 776K
Karyopharm Therapeutics KPTI:US USD 67.45M 465K
Ligand Pharmaceuticals LGND:US USD 70.48M 5.93M
Macrogenics MGNX:US USD 61.12M 5.57M
Neurocrine Biosciences NBIX:US USD 308.6M 8.5M
Pfizer PFE:US USD 19.12B 5.9B
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Rigel Pharmaceuticals RIGL:US USD 49.2M 8.39M
Sangamo Biosciences SGMO:US USD 82.62M 1.27M
Ultragenyx Pharmaceutical RARE:US USD 248.98M 66.79M
Veracyte VCYT:US USD 85.72M 445K